We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLE icon
1276
Allegion
ALLE
$14.1B
-34,721
Closed -$2.64M
ALNY icon
1277
Alnylam Pharmaceuticals
ALNY
$29.3B
-8,767
Closed -$447K
AMGN icon
1278
Amgen
AMGN
$210B
-62,084
Closed -$10.2M
AMPH icon
1279
Amphastar Pharmaceuticals
AMPH
$877M
-14,325
Closed -$215K
AMT icon
1280
American Tower
AMT
$81.7B
-25,346
Closed -$3.09M
AMWD
1281
DELISTED
American Woodmark
AMWD
-9,529
Closed -$877K
APH icon
1282
Amphenol
APH
$211B
-534,508
Closed -$9.49M
ARW icon
1283
Arrow Electronics
ARW
$11.6B
-50,974
Closed -$3.72M
ASML icon
1284
ASML
ASML
$658B
-82,339
Closed -$11M
ASR icon
1285
Grupo Aeroportuario del Sureste
ASR
$8.29B
-2,043
Closed -$353K
ATKR icon
1286
Atkore
ATKR
$3.16B
-115,914
Closed -$3.01M
AXTA icon
1287
Axalta
AXTA
$8.05B
-1,207,100
Closed -$38.6M
BALL icon
1288
Ball Corp
BALL
$17B
-27,830
Closed -$1.03M
BAP icon
1289
Credicorp
BAP
$31.2B
-59,900
Closed -$9.76M
BBWI icon
1290
Bath & Body Works
BBWI
$4.24B
-75,852
Closed -$2.88M
BBY icon
1291
Best Buy
BBY
$18.2B
-40,148
Closed -$1.97M
BDC icon
1292
Belden
BDC
$4.98B
-50,630
Closed -$3.49M
BDN
1293
Brandywine Realty Trust
BDN
$546M
-191,499
Closed -$3.06M
BEN icon
1294
Franklin Resources
BEN
$18.2B
-34,390
Closed -$1.44M
BIO icon
1295
Bio-Rad Laboratories Class A
BIO
$8.91B
-1,947
Closed -$387K
BNY
1296
Bank of New York Mellon
BNY
$106B
-39,440
Closed -$1.85M
BKE icon
1297
Buckle
BKE
$2.35B
-13,291
Closed -$253K
BPOP icon
1298
Popular Inc
BPOP
$11.2B
-12,453
Closed -$511K
CASH icon
1299
Pathward Financial
CASH
$1.89B
-43,461
Closed -$1.29M
CBOE icon
1300
Cboe Global Markets
CBOE
$30.1B
-3,159
Closed -$256K

Similar funds

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.